Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation

This study is not yet open for participant recruitment.

Verified by University of California, Los Angeles, April 2005

Sponsors and Collaborators:	University of California, Los Angeles Novartis
Information provided by:	University of California, Los Angeles
ClinicalTrials.gov Identifier:	NCT00203671

Purpose

The purposes of this study are:

To review past clinical use of mycophenolate mofetil (MMF) in kidney transplant patients;
To discover why doses were modified and how those modifications affected the survival and health of the transplanted kidney; and
To determine whether, therefore, the side effects of MMF that result in dose alterations are related to outcome.

Condition
Kidney Diseases

MedlinePlus related topics: Kidney Transplantation

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Retrospective Study
Official Title:	Mycophenolate Mofetil (MMF): A Long-Term Data Evaluation

Further study details as provided by University of California, Los Angeles:

Estimated Enrollment:

900

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00203671

Contacts

Contact: Alan H Wilkinson, MD	(310) 794-1781	awilkinson@mednet.ucla.edu
Contact: Vincent Basehart	(310) 794-8558	vbasehart@mednet.ucla.edu

Sponsors and Collaborators

University of California, Los Angeles

Novartis

Investigators

Principal Investigator:	Alan H Wilkinson, MD	University of California, Los Angeles
Study Chair:	Ralph Barbeito, Ph.D.	Novartis Pharmaceuticals

More Information

Study ID Numbers:	04-05-018-01
Study First Received:	September 12, 2005
Last Updated:	July 11, 2006
ClinicalTrials.gov Identifier:	NCT00203671
Health Authority:	United States: Institutional Review Board

Keywords provided by University of California, Los Angeles:

renal
transplant
kidney
rejection

MMF
Mycophenolate Mofetil
outcomes
Kidney Transplantation

Study placed in the following topic categories:

Urologic Diseases
Mycophenolic Acid
Mycophenolate mofetil
Kidney Diseases

Additional relevant MeSH terms:

Molecular Mechanisms of Pharmacological Action
Immunologic Factors
Antineoplastic Agents
Therapeutic Uses
Physiological Effects of Drugs

Enzyme Inhibitors
Antibiotics, Antineoplastic
Immunosuppressive Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 15, 2009